We are live on ! Find out more
AIM

Advantage Investment Management Portfolio holdings

AUM $128M
1-Year Est. Return 3.61%
This Fund
S&P 500
This Quarter Est. Return
+4.61%
1 Year Est. Return
+3.61%
3 Year Est. Return
+32.97%
5 Year Est. Return
+46.27%
10 Year Est. Return
AUM
$274M
AUM Growth
+$61.2M
Cap. Flow
+$53.2M
Cap. Flow %
19.42%
Top 10 Hldgs %
34.44%
Holding
1,018
New
125
Increased
259
Reduced
186
Closed
76
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THRM icon
801
Gentherm
THRM
$1.26B
$3K ﹤0.01%
100
TUR icon
802
iShares MSCI Turkey ETF
TUR
$213M
$3K ﹤0.01%
70
UST icon
803
ProShares Ultra 7-10 Year Treasury
UST
$15.1M
$3K ﹤0.01%
+50
New +$3.18K
VOX icon
804
Vanguard Communication Services ETF
VOX
$5.76B
$3K ﹤0.01%
33
AVTA
805
DELISTED
Avantax, Inc. Common Stock
AVTA
$3K ﹤0.01%
300
RSX
806
DELISTED
VanEck Russia ETF
RSX
$3K ﹤0.01%
184
CLR
807
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$3K ﹤0.01%
50
TIF
808
DELISTED
Tiffany & Co.
TIF
$3K ﹤0.01%
35
LM
809
DELISTED
Legg Mason, Inc.
LM
$3K ﹤0.01%
82
WIN
810
DELISTED
Windstream Holdings Inc
WIN
$3K ﹤0.01%
63
YHOO
811
DELISTED
Yahoo Inc
YHOO
$3K ﹤0.01%
80
FTR
812
DELISTED
Frontier Communications Corp.
FTR
$3K ﹤0.01%
44
BCR
813
DELISTED
CR Bard Inc.
BCR
$3K ﹤0.01%
15
ABEV icon
814
Ambev
ABEV
$46.7B
$2K ﹤0.01%
300
ARGT icon
815
Global X MSCI Argentina ETF
ARGT
$822M
$2K ﹤0.01%
81
AVXL icon
816
Anavex Life Sciences
AVXL
$313M
$2K ﹤0.01%
+500
New +$2.1K
BCRX icon
817
BioCryst Pharmaceuticals
BCRX
$2.41B
$2K ﹤0.01%
560
CNQ icon
818
Canadian Natural Resources
CNQ
$95B
$2K ﹤0.01%
123
CPRX
819
DELISTED
Catalyst Pharmaceutical
CPRX
$2K ﹤0.01%
1,500
CSQ icon
820
Calamos Strategic Total Return Fund
CSQ
$3.35B
$2K ﹤0.01%
150
-1,200
-89% -$12.5K
ECH icon
821
iShares MSCI Chile ETF
ECH
$1.06B
$2K ﹤0.01%
60
EWY icon
822
iShares MSCI South Korea ETF
EWY
$23.9B
$2K ﹤0.01%
30
FRO icon
823
Frontline
FRO
$8.79B
$2K ﹤0.01%
300
FTC icon
824
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.38B
$2K ﹤0.01%
47
-1,900
-98% -$96.6K
GLAD icon
825
Gladstone Capital
GLAD
$447M
$2K ﹤0.01%
+150
New +$2.45K

Similar funds

Advantage Investment Management's Q3 2016 Portfolio in Review

As of Q3 2016, Advantage Investment Management held 1,018 positions worth $274M, up 29% from $213M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Advantage Investment Management deployed $53.2M of net new capital in Q3 2016, opening 125 new positions and adding to 259 existing holdings. Its largest new stake was State Street SPDR Russell 1000 Low Volatility Focus ETF: 129,798 shares worth $8.44M.

By sector, the portfolio is most concentrated in Financials at 6.4% of assets, down from 7.5% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Invesco S&P 500 Equal Weight Health Care ETF, an estimated $6.14M trimmed.

  • Advantage Investment Management's largest Q3 2016 buy was State Street SPDR Russell 1000 Low Volatility Focus ETF: 129,798 shares worth $8.44M.
  • Advantage Investment Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q3 2016, an estimated $12.9M increase.
  • Advantage Investment Management's biggest Q3 2016 reduction was Invesco S&P 500 Equal Weight Health Care ETF, cutting an estimated $6.14M.
  • Advantage Investment Management fully exited Invesco Emerging Markets Sovereign Debt ETF in Q3 2016, selling an estimated $3.36M.
  • Advantage Investment Management's ten largest holdings make up 34% of its $274M portfolio in Q3 2016.
  • Advantage Investment Management opened 125 new positions and closed 76 in Q3 2016.
  • Advantage Investment Management's portfolio value rose 29% quarter-over-quarter to $274M.

Based on Advantage Investment Management's 13F filing for Q3 2016, filed 27 Mar 2017.